Literature DB >> 14638921

Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study.

Joachim H Ix1, Michael G Shlipak, Haiying H Liu, Nelson B Schiller, Mary A Whooley.   

Abstract

Chronic renal insufficiency (CRI) is a predictor of stroke, cardiovascular, and all-cause mortality, but the mechanisms responsible for these associations are unclear. Whether CRI was associated with severity of coronary artery disease (CAD) as measured by exercise stress echocardiography among outpatients with stable CAD was evaluated. This study is a cross-sectional analysis of the Heart and Soul study, a prospective cohort of patients with known CAD. Renal function was assessed by 24-h urine collection, and CRI was defined as measured creatinine clearance < or =60 ml/min. Exercise stress echocardiography was used to identify inducible ischemia, defined as any wall motion abnormality seen at stress but not at rest. Logistic regression was used to evaluate the association of CRI with exercise-induced ischemia after adjustment for cardiovascular risk factors. Participants with CRI composed 97 (23%) of the 431 participants and were characterized by older age, worse CAD, lower ejection fraction, greater left ventricular mass and higher C-reactive protein values. The prevalence of exercise-induced ischemia was also substantially greater in the participants with CRI (42% versus 23%; odds ratio [OR], 2.3; 95% confidence interval [CI], 1.4 to 3.8; P < 0.001). This association was minimally changed by adjustment for traditional cardiovascular risk factors and coronary disease history (OR, 2.0; 95% CI, 1.3 to 3.3; P < 0.01) and remained strong even after adjustment for C-reactive protein (OR, 2.3; 95% CI, 1.0 to 5.1; P = 0.04). CRI is strongly associated with exercise-induced ischemia in patients with CAD. The greater severity of atherosclerotic disease observed in patients with CRI may in part explain the association of CRI with increased cardiovascular risk among individuals with CAD.

Entities:  

Mesh:

Year:  2003        PMID: 14638921      PMCID: PMC2770344          DOI: 10.1097/01.asn.0000095642.25603.7a

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  21 in total

1.  Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening.

Authors:  N Rifai; P M Ridker
Journal:  Clin Chem       Date:  2001-01       Impact factor: 8.327

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.

Authors:  L Cortigiani; E Picano; C Coletta; F Chiarella; W Mathias; N Gandolfo; M De Alcantara; V Mazzoni; G F Gensini; P Landi
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

4.  Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.

Authors:  Luis M Ruilope; Antonio Salvetti; Kenneth Jamerson; Lennart Hansson; Ingrid Warnold; Hans Wedel; Alberto Zanchetti
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

5.  Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Authors:  J F Mann; H C Gerstein; J Pogue; J Bosch; S Yusuf
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391

6.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

7.  Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency.

Authors:  M Tonelli; C Bohm; S Pandeya; J Gill; A Levin; B A Kiberd
Journal:  Am J Kidney Dis       Date:  2001-03       Impact factor: 8.860

8.  Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease.

Authors:  M G Shlipak; J A Simon; D Grady; F Lin; N K Wenger; C D Furberg
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

9.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.

Authors:  Paul Muntner; Jiang He; Lee Hamm; Catherine Loria; Paul K Whelton
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

10.  Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery.

Authors:  A M Arruda; R B McCully; J K Oh; D W Mahoney; J B Seward; P A Pellikka
Journal:  Am J Cardiol       Date:  2001-05-01       Impact factor: 2.778

View more
  41 in total

1.  Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study.

Authors:  Carmen A Peralta; Mary A Whooley; Joachim H Ix; Michael G Shlipak
Journal:  Am J Hypertens       Date:  2006-09       Impact factor: 2.689

2.  The PRIME curriculum. Clinical research training during residency.

Authors:  R J Kohlwes; R L Shunk; A Avins; J Garber; S Bent; M G Shlipak
Journal:  J Gen Intern Med       Date:  2006-05       Impact factor: 5.128

3.  Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study.

Authors:  Ellen E Brodin; Sigrid K Brækkan; Anders Vik; Jan Brox; John-Bjarne Hansen
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

4.  Prognostic Implications of Chronic Kidney Disease on Patients Presenting with ST-Segment Elevation Myocardial Infarction with versus without Stent Thrombosis.

Authors:  Gilad Margolis; Shahar Vig; Nir Flint; Shafik Khoury; Michael Barkagan; Gad Keren; Yacov Shacham
Journal:  Cardiorenal Med       Date:  2017-01-28       Impact factor: 2.041

5.  Depression, stress, and quality of life in persons with chronic kidney disease: the Heart and Soul Study.

Authors:  Michelle C Odden; Mary A Whooley; Michael G Shlipak
Journal:  Nephron Clin Pract       Date:  2005-12-07

6.  Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study.

Authors:  Aoife O'Donovan; Thomas C Neylan; Thomas Metzler; Beth E Cohen
Journal:  Brain Behav Immun       Date:  2012-02-15       Impact factor: 7.217

7.  Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.

Authors:  David Singh; Mary A Whooley; Joachim H Ix; Sadia Ali; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

8.  Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.

Authors:  Joachim H Ix; Glenn M Chertow; Michael G Shlipak; Vincent M Brandenburg; Markus Ketteler; Mary A Whooley
Journal:  Nephrol Dial Transplant       Date:  2006-04-27       Impact factor: 5.992

9.  Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study.

Authors:  Steven M Stevens; Ramin Farzaneh-Far; Beeya Na; Mary A Whooley; Nelson B Schiller
Journal:  JACC Cardiovasc Imaging       Date:  2009-01

10.  Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Glenn M Chertow; Michael G Shlipak; Vincent M Brandenburg; Markus Ketteler; Mary A Whooley
Journal:  Circulation       Date:  2007-05-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.